Skip to main content Skip to main navigation menu Skip to site footer

Management of systemic lupus erythemathous with polymyositis overlap syndrome

Abstract

Peningkatan kasus SLE terjadi pada anak di Rumah Sakit Umum Sanglah, pada kasus yang jarang SLE bukan sebagai satu kesatuan namun tumpang tindih dengan penyakit jaringan ikat lainnya. Polymyositis adalah penyakit dengan gejala utama kelemahan otot yang berhubungan dengan nyeri otot. Polymyositis sangat jarang menjadi sindrom yang tumpang tindih dengan SLE, namun terjadi pada 4-6% pasien SLE. Tujuan dari penelitian ini adalah untuk menggambarkan manajemen dan temuan klinis pada SLE dan Polymyositis. Kasus ini seorang perempuan berusia 12 tahun yang mengalami artralgia dan mialgia selama 1 bulan, disertai demam selama 1 bulan, penurunan nafsu makan, ruam pada wajah, fotosensitifitas, mati rasa, kelemahan otot dan kesemutan pada kaki kanan. Diagnosis SLE dibuat berdasarkan kriteria diagnostik American College of Rheumatology. Pemeriksaan neurologis dan elektromiografi signifikan menunjukkan penurunan kekuatan motorik pada tungkai kanan bawah, atrofi gastrocnemius, steppage gait, dan penurunan sensasi sensorik pada dermatom L4-S1 kanan. Oleh karena itu dapat disimpulkan kasus ini adalah kasus sindrom SLE overlap dengan polymyositis. Pasien diobati dengan prednison 2 mg/kg/hari selama 2 minggu, dan juga diberikan ibuprofen 10 mg/kg/dosis untuk menghilangkan rasa sakit, dilanjutkan dengan pemberian azathioprin yang direncanakan selama satu tahun. Pasien menunjukkan hasil yang baik dengan hilangnya gejala dan pemeriksaan laboratorium normal. Kesimpulan dari penelitian ini adalah sindrom SLE overlap dengan polymyositis yang diobati dengan prednison dan ibuprofen dilanjutkan dengan azathioprin menunjukkan hasil yang baik dengan hilangnya gejala serta hasil pemeriksaan laboratorium yang normal.


There has been an increase in SLE cases among children in Sanglah General Hospital. In rare case there is a possibility SLE occurs not as a single entity but overlap with other connective tissue disease. Polymyositis is a disease with a main symptom of muscle weakness associated with muscle pain and swollen. Polymyositis very rarely becomes overlapping syndrome with SLE, occurring in 4-6% of SLE patients. The aim of this study is to describe clinical findings and management of SLE and Polymyositis. This case is a 12 year old girl presented with arthralgia and myalgia since one month before admission, accompanied by a 1 month episode of relapsing fever, decrease in appetite, facial rash, photosensitivity, muscle weakness numbness and tingling sensation on right foot. Diagnosis of SLE was based on the diagnostic criteria of the American College of Rheumatology. Neurologic examination and electromyography was significant for decrease in motoric power on right lower limb, gastrocnemius atrophy, steppage gait, and decrease in sensoric sensation of right L4-S1 dermatome. Hence, diagnose of SLE and polymyositis was concluded. This is a case of SLE overlap syndrome with polymyositis. Patient was treated with prednisone 2 mg/kg/day for 2 weeks, and also given ibuprofen 10 mg/kg/dose for pain relief, continued with azathioprin plan for one year. Patient showed good result with disappearance of symptomp and normal laboratory examination. The conclusion of the study is SLE overlap syndrome with polymyositis treated with prednison and ibuprofen continue with azathioprin showed good outcome with disappearance of symptomp and normal laboratory examination.

References

  1. Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M. The diagnosis and treatment of systemic lupus erythematosus. Dtsch Arztebl Int. 2015;112:423-32. doi: 10.3238/arztebl.2015.0423.
  2. Bertsias G, Cervera R, Boumpas DT. Systemic lupus erythematosus: Pathogenesis and clinical features. EULAR Textbook on Rheumatic Diseases. 2012:476-505.
  3. Akib AAP, Soepriadi M, Setiabudiawan B. Lupus eritematosus sistemik. Dalam: Akib AAP, Munasi Z, Kurniati N, penyunting. Buku Ajar Alergi-Imunologi. Edisi kedua. Jakarta; 2008; pp.345-72.
  4. Aggarwal A, Srivastava P. Childhood onset systemic lupus erythematosus: how is it different from adult SLE?. International Journal of Rheumatic Disease. 2015;18:182-91. doi: 10.1590/2175-8239-jbn-2018-0097.
  5. Tarr T, Derfalvi B, Gyori N, Szanto A, Siminszky Z, Malik A, Szabo AJ, Szegedi G, Zeher M. Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus. 2015; 24:796-803.
  6. doi: 10.1177/0961203314563817
  7. Keren DF. Antinuclear antibody testing. Clin Lab Med. 2002;22:447-74.
  8. Soto ME, Hernandez-Becerril N, Perez-Chiney C, Hernandez-Rizo A, Telich-Tarriba JE, Juarez-Orozco LE, Melendez G, Bojalil R. Predictive value of antinuclear antibodies in autoimmune diseases classified by clinical criteria; Analytical study in a specialized health institue, one uear follow-up. Results in Immunology. 2015:13-22. doi: 10.1016/j.rinim.2013.10.003.
  9. Gawad ERA, Mansour AI, Aziz YAA, Soliman AF, Pawzy RM. Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy. The Egyptian Journal of Immunology. 2014;21(1):57-65.
  10. Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: Potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody. Journal of The Association of Physicians of India. 2013;61:372-77.
  11. Pradhan VD, Patwardhan MM, Ghosh K. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies. India J Dermatol Venereol Leprol. 2010;76(2):145-49. doi: 10.4103/0378-6323.60558.
  12. Cozzani E, Drosera M, Gasparini G, Parodi A. Serology of lupus erythematosus: Correlation between immunopathological features and clinical aspects. Hindawi Publishing Corporation. 2014;1-13. doi: 10.1155/2014/321359.
  13. Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res. 2002;4:S279-93. doi: 10.1186/ar586.
  14. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol. 2002;22:431-56. doi:10.1146/annurev.immunol.22.012703.104549
  15. Maazoun F, Frikha F, Snoussi M, Kaddour N, Masmoudi H, Bahloul Z. Systemic lupus erythematosus-myositis overlap syndrome: report of 6 cases. Clinics and Practice. 2011;1(e89):189-92. doi: 10.4081/cp.2011.e89
  16. Pappu R. Polymyositis. Emedicine. 2016;1-18.
  17. Shankar S, Behera V. Advances in management of systemic lupus erythematosus. Journal of Mahatma Gandhi Institute of Medical Sciences. 2014;19(1):28-36. doi: 10.4103/0971-9903.126235
  18. Chiang LL, Lin YT, Chan HY, Chiang BL. Differential manifestations of prepubescent, pubescent and postpubescent pediatric patients with systemic lupus erythematosus: A retrospective study of 96 Chinese children and adolescents. Pediatric Rheumatology. 2012;10(12):1-9. Pediatric Rheumatology.2012; 10:12. doi: 10.1186/1546-0096-10-12
  19. Wichainun R, Kasitanon N, Wangkaew S, Hongsongkiat S, Sukitawut W, Louthrenoo W. Sensitinity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: A comparison using control sera obtained from healthy individuals and patients with multiple medical problems. Asian Pac J Allergy Immunol. 2013;31:292-8. doi: 10.12932/AP0272.31.4.2013.
  20. Bizzaro N, Villalta D, Giavarina D, Tozzoli R. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmunity Reviews. 2012;12:97-106. doi: 10.1016/j.autrev.2012.07.002.
  21. Feng X, Zou Y, Pan W, Wang X, Wu M, Zhang M, Tao J, Zhang Y, Tan K, Li J, Chen Z, Ding X, Qian X, Da Z, Wang M, Sun L. Association of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus. Lupus. 2014;23:327-34. doi: 10.1177/0961203313513508.

How to Cite

Gading, S., Wati, K. D. K., Witarini, K. A., Santoso, H., & Suwarba, I. G. N. (2019). Management of systemic lupus erythemathous with polymyositis overlap syndrome. Medicina, 50(3). https://doi.org/10.15562/medicina.v50i3.575

HTML
55

Total
25

Share

Search Panel